RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,537.25
-63.9 (-2.46%)
BSENSE

Nov 20

BSE+NSE Vol: 6.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 456242,
    "name": "RPG LifeScience.",
    "stock_name": "RPG LifeScience.",
    "full_name": "RPG Life Sciences Ltd",
    "name_url": "stocks-analysis/rpg-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,537.25",
    "chg": -63.9,
    "chgp": "-2.46%",
    "dir": -1,
    "prev_price": "2,601.15",
    "mcapval": "4,301.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532983,
    "symbol": "RPGLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE105J01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "6.39 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/rpg-lifescience-456242-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "RPG Life Sciences Ends Week Slightly Lower Despite Technical Recovery and Mixed Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-ends-week-slightly-lower-despite-technical-recovery-and-mixed-signals-4270840",
        "imagepath": "",
        "date": "2026-11-21 17:07:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Downgrade to Sell amid technical weakness and flat financials</p>\n                    <p><strong>16 Nov:</strong> Technical momentum shifts to sideways trend</p>\n                    <p><strong>19 Nov:</strong> Upgrade to Hold on technical improvements and stable fundamentals</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.2,537.25 (-0.56%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,571.35</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs...."
      },
      {
        "title": "RPG Life Sciences Ltd Upgraded to Hold on Technical Improvements and Stable Fundamentals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/rpg-life-sciences-ltd-upgraded-to-hold-on-technical-improvements-and-stable-fundamentals-4267678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/RPGLifeSciences_mojoScore_4267678.png",
        "date": "2026-11-19 08:22:43",
        "description": "RPG Life Sciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite flat quarterly results. The pharmaceutical and biotechnology company’s recent performance and market positioning warrant a closer look at the factors driving this change."
      },
      {
        "title": "RPG Life Sciences Ltd Faces Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-ltd-faces-technical-momentum-shift-amid-mixed-market-signals-4262999",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/RPGLifeSciences_technicaldot_4262999.png",
        "date": "2026-11-16 08:01:43",
        "description": "RPG Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture, with some signals pointing to caution while others suggest underlying strength, reflecting the stock’s nuanced market positioning as it trades near ₹2,551."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-sell-by-marketsmojo-4262433",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/RPGLifeSciences_mojoScore_4262433.png",
        "date": "2026-11-15 10:10:16",
        "description": "RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 November 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "RPG Life Sciences Declines 0.62% Despite Mixed Technical Signals and Downgrade",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-declines-062-despite-mixed-technical-signals-and-downgrade-4255859",
        "imagepath": "",
        "date": "2026-11-07 17:07:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Stock opens at Rs.2,548.10, declines 0.94% amid Sensex rally</p>\n                    <p><strong>Nov 3:</strong> Further dip to Rs.2,536.30 following downgrade announcement</p>\n                    <p><strong>Nov 4:</strong> Downgrade to Sell rating announced; technical momentum shifts noted</p>\n                    <p><strong>Nov 5:</strong> Mildly bullish technical shift lifts price to Rs.2,602.35 (+2.60%)</p>\n                    <p><strong>Nov 6:</strong> Price retreats to Rs.2,556.55 (-1.05%) closing the week lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "RPG Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4251316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/RPGLifeSciences_technicaldot_4251316.png",
        "date": "2026-11-05 08:02:50",
        "description": "RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, a detailed analysis of key technical indicators such as MACD, RSI, moving averages, and others reveals a complex picture with mixed signals that investors should carefully consider."
      },
      {
        "title": "RPG Life Sciences Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-4249848",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/RPGLifeSciences_technicaldot_4249848.png",
        "date": "2026-11-04 08:02:35",
        "description": "RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s long-term returns remain robust, though short-term price action signals caution for investors."
      },
      {
        "title": "RPG Life Sciences Ltd’s Volatile Week: -1.75% Amid Margin Pressures and Market Shifts",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-ltds-volatile-week--175-amid-margin-pressures-and-market-shifts-4246119",
        "imagepath": "",
        "date": "2026-10-31 17:05:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 26:</strong> Stock surges 5.29% to Rs.2,756.75 on valuation upgrade</p>\n                    <p><strong>Oct 27:</strong> Continued gains with 2.42% rise to Rs.2,823.50</p>\n                    <p><strong>Oct 29:</strong> Sharp 5.21% jump to Rs.2,995.65 amid strong volume</p>\n                    <p><strong>Oct 30:</strong> Intraday low hit Rs.2,749.55; closes down 14.13% at Rs.2,572.40</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,618.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..."
      },
      {
        "title": "RPG Life Sciences Ltd Reports Flat Quarterly Performance Amid Margin Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/rpg-life-sciences-ltd-reports-flat-quarterly-performance-amid-margin-pressure-4244809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/RPGLifeSciences_fintrenddot_4244809.png",
        "date": "2026-10-30 11:00:13",
        "description": "RPG Life Sciences Ltd has reported a flat financial performance for the quarter ended September 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving its highest-ever quarterly net sales of ₹211.64 crores, the company witnessed an 8.8% decline in profit after tax (PAT) compared to the average of the preceding four quarters, signalling margin pressures and a cautious outlook for investors."
      }
    ],
    "total": 105,
    "sid": "456242",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/rpg-life-sciences-456242"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-Nov-2026",
      "details": "Earning call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Oct-2026",
      "details": "Newspaper publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "30-Oct-2026",
      "details": "Audio Recording of Q2FY27 Results Earnings Call held on October 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "RPG Life Sciences Ltd has declared <strong>300%</strong> dividend, ex-date: 09 Jul 26",
          "dt": "2026-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

05-Nov-2026 | Source : BSE

Earning call Transcript

Announcement under Regulation 30 (LODR)-Newspaper Publication

31-Oct-2026 | Source : BSE

Newspaper publication

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

30-Oct-2026 | Source : BSE

Audio Recording of Q2FY27 Results Earnings Call held on October 30 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

RPG Life Sciences Ltd has declared 300% dividend, ex-date: 09 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available